Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
Public ClinicalTrials.gov record NCT00469729. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Multi-National, Historical Cohort Controlled Study to Evaluate Efficacy and Safety of Transplantation of StemEx®, Umbilical Cord Blood Stem and Progenitor Cells Expanded Ex Vivo, in Subjects With Hematologic Malignancies Following Myeloablative Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the efficacy and safety of transplanting StemEx® in patients with certain hematological malignancies. For these patients, it is suggested that StemEx® can improve upon the outcome of transplanting a single, unmanipulated cord blood unit by significantly increasing the number of stem/progenitor cells available to the patient.
Study identification
- NCT ID
- NCT00469729
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 101 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2007
- Primary completion
- Jan 31, 2013
- Completion
- May 31, 2015
- Last update posted
- Jul 9, 2015
2007 – 2015
United States locations
- U.S. sites
- 16
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA's Jonsson Comprehensive Cancer Center | Los Angeles | California | 90095-1781 | — |
| Children's Hospital of Orange County | Orange | California | 92868-3874 | — |
| The Children's Hospital, B115, University of Colorado Health Sciences Center | Aurora | Colorado | 80045 | — |
| Northwestern University School of Medicine, Stem Cell Transplant Program, Children's Memorial Hospital | Chicago | Illinois | 60614 | — |
| Cardinal Bernardin Cancer Center, Loyola University Stritch School of Medicine | Maywood | Illinois | 60153 | — |
| The Cancer Center at Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Cornell University, Joan & Sanford I. Weill Medical College | New York | New York | NY 10065 | — |
| Steven and Alexandra Cohen Children's Medical Center of New York | New York | New York | — | — |
| Mount Sinai Medical Center | One Gustave L Levy Place, BOX 1410, New York | New York | 10029 | — |
| Case Western Reserve University | Cleveland | Ohio | 44106 | — |
| The Western Pennsylvania Hospital | Pittsburgh | Pennsylvania | 15224 | — |
| University of Pittsburgh Cancer Institute/UPMC Cancer Centers | Pittsburgh | Pennsylvania | 15232 | — |
| Texas Transplant Institute | San Antonio | Texas | 78229 | — |
| University of Virginia, Hematopoietic Stem Cell Transplant Program | West Complex 1300 Jefferson Park Av, Charlottesville | Virginia | 22903 | — |
| Medical College of Wisconsin Division of Neoplastic Diseases and Related Disorders | Milwaukee | Wisconsin | 53226 | — |
| Medical College of Wisconsin Pediatric Blood and Marrow Transplant Program | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00469729, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 9, 2015 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00469729 live on ClinicalTrials.gov.